AGA
IONS icon

Altrinsic Global Advisors’s Ionis Pharmaceuticals IONS Stock Holding History

Altrinsic Global Advisors’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-182,734
Closed -$7.32M – 48
2024
Q3 		$7.32M Sell
182,734
-5,097
-3% -$237K 0.31% 37
2024
Q2 		$8.95M Sell
187,831
-7,033
-4% -$288K 0.4% 35
2024
Q1 		$8.45M Sell
194,864
-14,288
-7% -$681K 0.38% 34
2023
Q4 		$10.6M Sell
209,152
-83,032
-28% -$3.98M 0.45% 29
2023
Q3 		$13.3M Sell
292,184
-15,806
-5% -$652K 0.51% 30
2023
Q2 		$12.6M Sell
307,990
-14,291
-4% -$549K 0.48% 32
2023
Q1 		$11.5M Buy
322,281
+3,107
+1% +$117K 0.45% 34
2022
Q4 		$12.1M Buy
319,174
+157,928
+98% +$6.64M 0.51% 30
2022
Q3 		$7.13M Sell
161,246
-25,208
-14% -$1.06M 0.33% 39
2022
Q2 		$6.9M Sell
186,454
-21,704
-10% -$818K 0.28% 41
2022
Q1 		$7.71M Sell
208,158
-191,234
-48% -$6.26M 0.27% 42
2021
Q4 		$12.2M Sell
399,392
-45,495
-10% -$1.43M 0.39% 40
2021
Q3 		$14.9M Sell
444,887
-11,339
-2% -$427K 0.45% 42
2021
Q2 		$18.2M Buy
456,226
+15,172
+3% +$594K 0.55% 39
2021
Q1 		$19.8M Buy
441,054
+98,280
+29% +$5.48M 0.62% 38
2020
Q4 		$19.4M Sell
342,774
-1,178
-0.3% -$58.7K 0.66% 36
2020
Q3 		$16.3M Buy
343,952
+3,052
+0.9% +$170K 0.67% 34
2020
Q2 		$20.1M Sell
340,900
-7,934
-2% -$441K 0.88% 30
2020
Q1 		$16.5M Buy
348,834
+77,266
+28% +$4.31M 0.91% 32
2019
Q4 		$16.4M Sell
271,568
-17,630
-6% -$1.05M 0.69% 34
2019
Q3 		$17.3M Buy
289,198
+110,384
+62% +$7.19M 0.75% 33
2019
Q2 		$11.5M Sell
178,814
-58,831
-25% -$4.16M 0.53% 39
2019
Q1 		$19.3M Sell
237,645
-290,614
-55% -$18.7M 0.89% 32
2018
Q4 		$28.6M Buy
528,259
+4,041
+0.8% +$206K 1.37% 23
2018
Q3 		$27M Buy
524,218
+2,703
+0.5% +$127K 1.22% 30
2018
Q2 		$21.7M Buy
521,515
+79,390
+18% +$3.52M 0.86% 36
2018
Q1 		$19.5M Sell
442,125
-22,435
-5% -$1.14M 0.79% 35
2017
Q4 		$23.4M Sell
464,560
-139,895
-23% -$7.67M 0.9% 36
2017
Q3 		$30.6M Sell
604,455
-70,633
-10% -$3.7M 1.16% 25
2017
Q2 		$34.3M Sell
675,088
-126,288
-16% -$5.88M 1.24% 23
2017
Q1 		$32.2M Sell
801,376
-119,798
-13% -$5.38M 1.09% 31
2016
Q4 		$44.1M Sell
921,174
-112,307
-11% -$4.44M 1.63% 22
2016
Q3 		$37.9M Sell
1,033,481
-337,895
-25% -$10.6M 1.39% 25
2016
Q2 		$31.9M Buy
1,371,376
+753,490
+122% +$24.3M 0.9% 38
2016
Q1 		$25M Buy
617,886
+410,129
+197% +$16.7M 0.7% 47
2015
Q4 		$12.9M Hold
207,757
– – 0.33% 50
2015
Q3 		$8.4M Buy
207,757
+85,000
+69% +$4.4M 0.19% 53
2015
Q2 		$7.07M Hold
122,757
– – 0.14% 54
2015
Q1 		$7.82M Sell
122,757
-421,826
-77% -$28.6M 0.17% 52
2014
Q4 		$33.6M Sell
544,583
-717,212
-57% -$35.4M 0.7% 43
2014
Q3 		$49M Buy
1,261,795
+939,038
+291% +$33.3M 0.93% 37
2014
Q2 		$11.1M Buy
322,757
+150,000
+87% +$4.72M 0.2% 51
2014
Q1 		$7.46M Buy
172,757
+30,000
+21% +$1.45M 0.13% 55
2013
Q4 		$5.69M Buy
142,757
+42,757
+43% +$1.52M 0.1% 55
2013
Q3 		$3.75M Buy
+100,000
New +$2.99M 0.06% 60

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
TBC
Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return

Altrinsic Global Advisors's IONS Position: Q4 2024 in Review

Altrinsic Global Advisors sold out of Ionis Pharmaceuticals (IONS) in Q4 2024, closing a stake of 182,734 shares — an estimated $7.32M sold.

Altrinsic Global Advisors first reported a position in IONS in Q3 2013 and held it in 45 quarters. The position peaked at $49M in Q3 2014. 354 funds tracked by Wall St. Rank hold IONS as of Q4 2024.

  • Altrinsic Global Advisors reported no remaining Ionis Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Altrinsic Global Advisors sold 182,734 Ionis Pharmaceuticals shares in Q4 2024, an estimated $7.32M.
  • Altrinsic Global Advisors first reported a position in Ionis Pharmaceuticals in Q3 2013 and held it in 45 quarters.
  • Altrinsic Global Advisors's Ionis Pharmaceuticals position peaked at $49M in Q3 2014.
  • 354 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2024.

Based on Altrinsic Global Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.